Germline genome-wide association studies in women receiving neoadjuvant chemotherapy with or without bevacizumab

Neoadjuvant chemotherapy (NAC) for breast cancer is widely employed and we performed genome-wide association studies (GWAS) to determine if germline genetic variability was associated with benefit in terms of pathological complete response (pCR), disease-free survival (DFS), and overall survival (OS...

詳細記述

保存先:
書誌詳細
出版年:Pharmacogenet Genomics
主要な著者: Ingle, James N., Kalari, Krishna R., Wickerham, D. Lawrence, von Minckwitz, Gunter, Fasching, Peter A., Furukawa, Yoichi, Mushiroda, Taisei, Goetz, Matthew P., Barman, Poulami, Carlson, Erin E., Rastogi, Priya, Costantino, Joseph P., Cairns, Junmei, Paik, Soonmyung, Bear, Harry D., Kubo, Michiaki, Wang, Liewei, Wolmark, Norman, Weinshilboum, Richard M.
フォーマット: Artigo
言語:Inglês
出版事項: 2018
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5965682/
https://ncbi.nlm.nih.gov/pubmed/29768301
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/FPC.0000000000000337
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料